Nurix Therapeutics, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US67080M1036
USD
18.02
1.67 (10.21%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Nov'24
Nov'23
Nov'22
Nov'21
Nov'20
Nov'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
526.99
200.49
303.70
342.30
290.27
-9.52
Shareholder's Funds
526.99
200.49
303.70
342.30
290.27
-9.52
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
8.01
7.49
5.53
3.85
0.00
0.00
Secured Loans
8.01
7.49
5.53
3.85
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Other Long Term Liabilities
52.59
77.09
45.71
71.54
61.53
37.43
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
52.58
77.09
45.71
71.54
61.53
37.43
Current Liabilities
Trade Payables
11.48
6.40
5.06
6.65
3.41
1.60
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
95.85
86.96
70.66
66.26
44.54
16.14
Total Liabilities
675.43
364.54
420.06
480.10
396.34
44.05
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
80.40
74.20
49.18
40.22
19.86
14.87
Less: Accumulated Depreciation
34.50
26.25
19.67
14.88
13.18
11.00
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
45.90
47.95
29.51
25.34
6.67
3.87
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.90
8.32
64.78
137.47
91.06
0.68
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
3.06
3.32
3.52
2.33
0.18
0.15
Total Non-Current Assets
56.05
69.04
101.61
168.98
97.91
4.69
Current Assets Loans & Advances
Current Investments
499.59
233.28
244.67
215.21
161.79
2.90
Inventories
0.00
0.00
0.00
0.00
0.00
0.00
Sundry Debtors
0.00
0.00
0.00
6.00
7.50
0.00
Cash and Bank
110.00
54.63
64.47
80.51
119.36
34.82
Other Current Assets
611.08
288.71
310.24
302.82
292.49
37.72
Short Term Loans and Advances
0.00
0.00
1.10
1.10
3.85
0.00
Total Current Assets
619.39
295.50
318.45
311.12
298.43
39.35
Net Current Assets (Including Current Investments)
523.53
208.54
247.79
244.86
253.90
23.22
Total Current Assets Excluding Current Investments
619.39
295.50
318.45
311.12
298.43
39.35
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
675.43
364.54
420.06
480.10
396.34
44.05
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
8.01
7.49
5.53
3.85
0.00
0.00
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

No Borrowings in the last few periods;

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Nov 2024 is -31.78% vs 68.65% in Nov 2023

stock-summary

Fixed Assets

YoY Growth in year ended Nov 2024 is -4.28% vs 62.49% in Nov 2023

stock-summary

Investments

YoY Growth in year ended Nov 2024 is -89.18% vs -87.16% in Nov 2023

stock-summary

Current Assets

YoY Growth in year ended Nov 2024 is 109.61% vs -7.21% in Nov 2023

Compare Balance Sheet Results of Nurix Therapeutics, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
526.99
590.33
-63.34
-10.73%
Shareholder's Funds
526.99
590.33
-63.34
-10.73%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
8.01
1.30
6.71
516.15%
Secured Loans
8.01
1.30
6.71
516.15%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0
0.00
0.00%
Other Long Term Liabilities
52.59
1.45
51.14
3,526.90%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
52.58
1.45
51.13
3,526.21%
Current Liabilities
Trade Payables
11.48
1.68
9.80
583.33%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
95.85
30.65
65.20
212.72%
Total Liabilities
675.43
622.43
53.00
8.52%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
80.40
3.01
77.39
2,571.10%
Less: Accumulated Depreciation
34.50
0.66
33.84
5,127.27%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
45.90
2.35
43.55
1,853.19%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
0.90
204.44
-203.54
-99.56%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
3.06
0.37
2.69
727.03%
Total Non-Current Assets
56.05
207.76
-151.71
-73.02%
Current Assets Loans & Advances
Current Investments
499.59
315.97
183.62
58.11%
Inventories
0
0
0.00
0.00%
Sundry Debtors
0
0
0.00
0.00%
Cash and Bank
110.00
83.00
27.00
32.53%
Other Current Assets
611.08
401.98
209.10
52.02%
Short Term Loans and Advances
0
0
0.00
0.00%
Total Current Assets
619.39
414.67
204.72
49.37%
Net Current Assets (Including Current Investments)
523.53
384.02
139.51
36.33%
Total Current Assets Excluding Current Investments
619.39
414.67
204.72
49.37%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
675.43
622.43
53.00
8.52%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
8.01
1.30
6.71
516.15%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Markets Mojo
No Borrowings in the last few periods
stock-summary

No Borrowings in the last few periods;

Annual - Other Long Term Liabilities
Other Long Term Liabilities 52.59 Million
in Nov 2024

Figures in Million
stock-summary

YoY Growth in year ended Nov 2024 is -31.78% vs 68.65% in Nov 2023

Annual - Fixed Assets
Fixed Assets 45.90 Million
in Nov 2024

Figures in Million
stock-summary

YoY Growth in year ended Nov 2024 is -4.28% vs 62.49% in Nov 2023

Annual - Investments
Investments 0.90 Million
in Nov 2024

Figures in Million
stock-summary

YoY Growth in year ended Nov 2024 is -89.18% vs -87.16% in Nov 2023

Annual - Current Assets
Current Assets 619.39 Million
in Nov 2024

Figures in Million
stock-summary

YoY Growth in year ended Nov 2024 is 109.61% vs -7.21% in Nov 2023